Business Uncategorized For now, Covaxin’s claim of efficacy against omicron is little science and a lot of conjecture 3 years ago
Business Uncategorized A new study of India’s Covaxin could be a precursor to its booster dose policy 3 years ago
Business Uncategorized The UK will allow Indian travelers who got Covaxin to skip quarantine 3 years ago
Business Uncategorized Will the WHO’s Covaxin approval answer questions about the vaccine’s trials? 3 years ago
Business Uncategorized How many vaccines is India making? The government has many answers to one question 3 years ago
Business Uncategorized India’s homegrown Covid vaccine is running into deeper troubles abroad 3 years ago
Business Uncategorized Will India meet its target of vaccinating 300 million people by August? 3 years ago
USA
USA